180 WEALTH ADVISORS, LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 66 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.0%.

Quarter-by-quarter ownership
180 WEALTH ADVISORS, LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$26,000
-25.7%
25,0000.0%0.01%
-31.2%
Q2 2019$35,000
-18.6%
25,0000.0%0.02%
-20.0%
Q1 2019$43,000
-46.9%
25,000
-16.7%
0.02%
-47.4%
Q4 2018$81,0000.0%30,0000.0%0.04%
+2.7%
Q3 2018$81,000
+42.1%
30,0000.0%0.04%
+32.1%
Q2 2018$57,000
+35.7%
30,000
+50.0%
0.03%
+27.3%
Q1 2018$42,00020,0000.02%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 1,476,000$819,1800.18%
BVF INC/IL 6,353,645$3,526,2730.15%
Gratus Capital, LLC 1,323,598$734,6000.06%
Bleichroeder LP 250,000$138,7500.03%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$302,7570.01%
Callan Capital, LLC 158,500$87,9680.01%
Polar Capital Holdings Plc 2,071,242$1,149,5390.01%
Virtu Financial LLC 66,537$370.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 249,000$138,1950.00%
Pacific Sage Partners, LLC 17,500$9,7130.00%
View complete list of INFINITY PHARMACEUTICALS INC shareholders